This is how pharma works: pharma entities in the US dont make any profit, because they send royalty to the IP holder entity in Switzerland, where these royalty payments are taxes at the lowest rate possible and profits are sheltered that way from the US and EU taxation
https://www.investigate-europe.eu/posts/deadly-prices-pharma...
1. https://en.wikipedia.org/wiki/Double_Irish_arrangement
They're going to do the same thing in Europe (where the US tariffs don't apply).
Subscription-based features that are already built into the car and only activated by software have been talked about since at least 2020.
Car companies have been leaning on (BS, IMO) software revenue since the days of the $100+ GPS data update sticks, at the latest.
I don't think this is the future any consumer wants, but it's the one we're gonna get from every industry where money can be turned on with the flip of a Boolean.